
Sign up to save your podcasts
Or


Sam Kulkarni, PhD, CEO and Chairman of CRISPR Therapeutics, joins Venrock's Nimish Shah for a conversation about how they're using gene editing to find potential cures so miraculous, it almost sounds like science fiction. Sam shares advice on how to fundraise in the extraordinarily capital-intensive biotech market, having the courage to go after difficult things and face detractors, and how CEOs should find opportunity in volatility.
By Venrock, a venture capital firm4.8
6262 ratings
Sam Kulkarni, PhD, CEO and Chairman of CRISPR Therapeutics, joins Venrock's Nimish Shah for a conversation about how they're using gene editing to find potential cures so miraculous, it almost sounds like science fiction. Sam shares advice on how to fundraise in the extraordinarily capital-intensive biotech market, having the courage to go after difficult things and face detractors, and how CEOs should find opportunity in volatility.

1,288 Listeners

2,690 Listeners

2,453 Listeners

1,089 Listeners

338 Listeners

320 Listeners

391 Listeners

5,554 Listeners

9,927 Listeners

34 Listeners

511 Listeners

18 Listeners

282 Listeners

467 Listeners

1,427 Listeners